794118988	794118988	CD	B-NP	O
|	|	NN	I-NP	O
EGH	EGH	NN	I-NP	O
|	|	NN	I-NP	O
21914410	21914410	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5532811	5532811	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2005	10/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-DNA
CHF	CHF	NNP	I-NP	I-DNA
flare	flare	NN	I-NP	I-DNA
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/4/2005	3/4/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/19/2005	4/19/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
LEBEL	LEBEL	NN	B-NP	B-protein
,	,	,	O	O
LUCIEN	LUCIEN	NN	B-NP	O
559-17-71-0	559-17-71-0	CD	I-NP	O
O	O	NNP	I-NP	O
Westhend	Westhend	NNP	I-NP	O
Gle	Gle	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/21/05	2/21/05	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TAKAI	TAKAI	NN	B-NP	B-protein
,	,	,	O	O
AARON	AARON	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/1/05	9/1/05	CD	B-NP	O
by	by	IN	B-PP	O
LEGER	LEGER	NNP	B-NP	O
,	,	,	O	O
GROVER	GROVER	NNP	B-NP	O
G	G	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
28736308	28736308	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
50	50	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
September	September	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
NPH	NPH	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
September	September	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
August	August	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
every	every	DT	B-NP	O
Monday	Monday	NNP	I-NP	O
,	,	,	O	O
Wed	Wed	NNP	B-NP	O
,	,	,	O	O
Fri	Fri	NNP	B-NP	O
,	,	,	O	O
Sat	Sat	NNP	B-NP	B-protein
,	,	,	O	O
Sun	Sun	NNP	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/1/05	9/1/05	CD	B-NP	O
by	by	IN	B-PP	O
PALLA	PALLA	NNP	B-NP	O
,	,	,	O	O
REYES	REYES	NNP	B-NP	O
H	H	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
27879391	27879391	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/1/05	9/1/05	CD	B-NP	O
by	by	IN	B-PP	O
IZZO	IZZO	NNP	B-NP	O
,	,	,	O	O
ROCKY	ROCKY	NNP	B-NP	O
R	R	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
PAXIL	PAXIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PAROXETINE	PAROXETINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
SEROQUEL	SEROQUEL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QUETIAPINE	QUETIAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
800	800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
DEPAKOTE	DEPAKOTE	NN	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
DIVALPROEX	DIVALPROEX	NN	I-NP	B-protein
SODIUM	SODIUM	NN	I-NP	I-protein
ER	ER	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/3/05	2/3/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
PROTONIX	PROTONIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dorsey	Dorsey	NNP	B-NP	O
Deases	Deases	NNP	I-NP	O
August	August	NNP	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lavern	Lavern	NNP	I-NP	O
Bringhurst	Bringhurst	NNP	I-NP	O
February	February	NNP	I-NP	O
scheduled	schedule	VBD	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
9/6/05	9/6/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lesley	Lesley	NNP	I-NP	O
Bertling	Bertling	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Aflutter	Aflutter	NN	B-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
flare	flare	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NNP	B-NP	O
2000	2000	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
S/P	S/P	NN	I-NP	B-protein
myocardial	myocardial	JJ	I-NP	I-protein
infarction	infarction	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
PE	PE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
embolism	embolism	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Schizophrenia	Schizophrenia	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
schizophrenia	schizophrenia	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
gut	gut	NN	I-NP	I-protein
malrotation	malrotation	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Atrial	Atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
dysfunctional	dysfunctional	JJ	I-NP	O
uterine	uterine	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dysfunctional	dysfunctional	JJ	I-NP	O
uterine	uterine	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
uterine	uterine	JJ	I-NP	O
fibroid	fibroid	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
uterine	uterine	JJ	I-NP	O
fibroids	fibroid	NNS	I-NP	O
-RRB-	-RRB-	WDT	B-NP	O
h/o	h/o	NN	I-NP	O
rheumatic	rheumatic	JJ	I-NP	O
fever	fever	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
rheumatic	rheumatic	JJ	I-NP	O
fever	fever	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
c-section	c-section	NN	I-NP	O
x2	x2	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cesarean	cesarean	JJ	I-NP	O
section	section	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CXR	CXR	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
clear	clear	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
-	-	HYPH	O	O
Aflutter	Aflutter	NNP	B-NP	O
Lower	Lower	NNP	I-NP	O
Extremity	Extremity	NNP	I-NP	O
Vascular	Vascular	NNP	I-NP	O
Ultrasound	Ultrasound	NNP	I-NP	O
-	-	HYPH	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
bilaterally	bilaterally	RB	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
52	52	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
--	--	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
--	--	:	O	O
DX	DX	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
52	52	CD	B-NP	O
yr	yr	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
DM	DM	NN	I-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
MI	MI	NNP	B-NP	O
2000	2000	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
A	A	DT	B-NP	O
fib/flutter	fib/flutter	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
patient	patient	NN	B-NP	O
-	-	HYPH	O	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
to	to	TO	B-VP	O
ED	ED	VB	I-VP	O
because	because	IN	B-SBAR	O
CHF	CHF	NN	B-NP	O
nurse	nurse	NN	I-NP	O
noted	note	VBD	B-VP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
describes	describe	VBZ	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
swelling	swell	VBG	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increasing	increase	VBG	I-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
sleep	sleep	VB	I-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
,	,	,	O	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
her	her	PRP$	B-NP	B-protein
usual	usual	JJ	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

1	1	CD	B-NP	O
day	day	NN	I-NP	O
PTA	PTA	NN	I-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
L	L	NN	I-NP	O
lower	low	JJR	I-NP	O
leg	leg	NN	I-NP	O
,	,	,	O	O
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
knot	knot	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
calf	calf	NN	I-NP	O
.	.	.	O	O
''	''	''	O	O

Day	Day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
noticed	notice	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
+10	+10	CD	B-NP	O
lbs	lb	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
+	+	SYM	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
patient	patient	NN	I-NP	O
becomes	become	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
climbing	climb	VBG	B-VP	O
2	2	CD	B-NP	O
stairs	stair	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
cp	cp	NN	B-NP	B-DNA
,	,	,	O	O
n/v/d	n/v/d	NN	B-NP	O
.	.	.	O	O

Admits	Admit	NNS	B-NP	O
auditory	auditory	JJ	I-NP	O
and	and	CC	I-NP	O
visual	visual	JJ	I-NP	O
hallucinations	hallucination	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
men	man	NNS	I-NP	O
and	and	CC	I-NP	O
women	woman	NNS	I-NP	O
crawling	crawl	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
wall	wall	NN	I-NP	O
saying	say	VBG	B-VP	O
things	thing	NNS	B-NP	O
about	about	IN	B-PP	O
me	me	PRP	B-NP	O
-RRB-	-RRB-	NNP	B-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Htn	Htn	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NNP	B-NP	O
2000	2000	CD	I-NP	O
,	,	,	O	O
Rheumatic	Rheumatic	JJ	B-NP	B-protein
Fever	Fever	NNP	I-NP	I-protein
c	c	NN	I-NP	I-protein
valve	valve	NN	I-NP	I-protein
dz	dz	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
Depression	Depression	NNP	B-NP	O
,	,	,	O	O
Schizophrenia	Schizophrenia	NNP	B-NP	O
,	,	,	O	O
Afib/flutter	Afib/flutter	NNP	B-NP	O
,	,	,	O	O
Fibroids	Fibroids	NNP	B-NP	O
,	,	,	O	O
Dysfunctional	Dysfunctional	NNP	B-NP	O
Uterine	Uterine	NNP	I-NP	O
Bleeding	Bleeding	NNP	I-NP	O
,	,	,	O	O
h/o	h/o	DT	O	O
PE	PE	NNP	B-NP	O
,	,	,	O	O
h/o	h/o	JJ	B-NP	O
domestic	domestic	JJ	I-NP	O
violence	violence	NN	I-NP	O
--	--	:	O	O
EVENTS	EVENTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
A	A	NN	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
110s	110	NNS	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
x	x	SYM	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
brought	bring	VBD	B-VP	O
her	her	PRP$	B-NP	O
HR	HR	NN	I-NP	B-protein
down	down	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
described	describe	VBD	B-VP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
for	for	IN	B-PP	O
seconds	second	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
described	describe	VBN	I-VP	O
as	as	IN	B-PP	O
sharp	sharp	JJ	B-NP	O
,	,	,	I-NP	O
midline	midline	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pleuritic	pleuritic	JJ	B-ADJP	O
.	.	.	O	O

7/5	7/5	CD	B-NP	O
-	-	HYPH	I-NP	O
no	no	DT	B-NP	O
O/N	O/N	NN	I-NP	B-protein
events	event	NNS	I-NP	I-protein
4/21	4/21	CD	I-NP	I-protein
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
O/N	O/N	NN	I-NP	O
events	event	NNS	I-NP	O
--	--	:	O	O
STATUS	STATUS	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
97.1	97.1	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
106/67	106/67	CD	I-NP	I-DNA
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
18	18	CD	I-NP	I-protein
,	,	,	O	O
O2sat	O2sat	NN	B-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
GEN	GEN	NN	I-NP	I-protein
:	:	:	O	O
breathing	breathing	NN	B-NP	O
comfortably	comfortably	RB	B-ADVP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
NECK	NECK	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
CV	CV	NN	I-NP	O
:	:	:	O	O
NL	NL	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
MRG	MRG	NN	I-NP	O
's	's	POS	B-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

soft	soft	JJ	B-ADJP	O
.	.	.	O	O

NT	NT	NN	B-NP	O
.	.	.	O	O

mild	mild	JJ	B-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
or	or	CC	I-NP	O
bruits	bruit	NNS	I-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
DP	DP	NN	B-NP	O
and	and	CC	O	O
TP	TP	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
+	+	SYM	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
calf	calf	NN	I-NP	O
,	,	,	O	O
ankle	ankle	DT	B-NP	O
tender	tender	NN	I-NP	O
anteriorly	anteriorly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
posteriorly	posteriorly	RB	I-ADVP	O
.	.	.	O	O

+	+	SYM	O	O
Homan	Homan	NNP	B-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
STUDIES/TESTS	STUDIES/TESTS	NN	B-NP	O
:	:	:	O	O
5/12/05	5/12/05	CD	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
mild	mild	JJ	B-NP	O
kyphosis	kyphosis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
cardiomegaly	cardiomegaly	RB	I-NP	O
no	no	DT	I-NP	O
change	change	NN	I-NP	O
since	since	IN	B-PP	O
11/5/05	11/5/05	CD	B-NP	O
8	8	CD	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	O
118	118	CD	I-NP	O
,	,	,	O	O
A	A	DT	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
7/20/05	7/20/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
showed	show	VBD	B-VP	O
A	A	DT	B-NP	O
fib	fib	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
A	A	NN	I-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

4/21	4/21	CD	B-NP	O
-	-	HYPH	I-NP	O
Bilat	Bilat	NN	I-NP	O
Lenis	Lenis	NN	I-NP	O
-	-	HYPH	B-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
--	--	:	O	O
PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Pulm	Pulm	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
Currently	Currently	RB	I-VP	O
treating	treat	VBG	I-VP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
-	-	HYPH	B-NP	O
etiology	etiology	NN	I-NP	O
likely	likely	RB	B-NP	O
diet	diet	NN	I-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

Very	Very	JJ	B-NP	O
mild	mild	JJ	I-NP	O
BLE	BLE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
inc	inc	NN	B-NP	O
abd	abd	NN	I-NP	O
girth	girth	NN	I-NP	O
and	and	CC	O	O
wt	wt	NN	B-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

Ischemia	Ischemia	NNP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	I-NP	O
I	I	NN	I-NP	O
:	:	:	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
x3	x3	CD	B-NP	I-protein
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
Metop	Metop	NNP	B-NP	O
,	,	,	O	O
Statin	Statin	NNP	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	B-protein
P	P	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
likely	likely	JJ	B-NP	O
minor	minor	JJ	I-NP	O
flare	flare	NN	I-NP	O
2/2	2/2	CD	I-NP	O
diet	diet	NN	I-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
R	R	NNP	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
Afib/flutter	Afib/flutter	NNP	B-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
goes	go	NNS	B-NP	O
in	in	IN	B-PP	O
and	and	CC	I-PP	O
out	out	IN	I-PP	O
,	,	,	O	O
but	but	CC	O	O
pt	pt	JJ	B-NP	O
states	state	NNS	I-NP	O
always	always	RB	B-ADVP	O
in	in	IN	B-PP	O
Afib	Afib	NNP	B-NP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
-	-	HYPH	O	O
last	last	JJ	B-NP	O
INR	INR	NN	I-NP	O
2.8	2.8	CD	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Endo	Endo	AFX	O	B-protein
-	-	HYPH	O	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
-	-	HYPH	B-NP	O
FS	FS	NN	I-NP	O
high	high	JJ	B-ADJP	O
on	on	IN	B-PP	O
HD1	HD1	NN	B-NP	B-protein
,	,	,	O	O
now	now	RB	B-ADVP	O
140s	140s	CD	B-NP	O
-150	-150	CD	I-NP	O
s	s	NN	I-NP	O
after	after	IN	B-PP	O
increased	increase	VBN	B-NP	O
NPH	NPH	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
QAM	QAM	NN	I-NP	O
and	and	CC	I-NP	O
QPM	QPM	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
cont	cont	NN	I-NP	O
RISS	RISS	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Psych	Psych	NN	I-NP	O
-	-	HYPH	I-NP	O
h/o	h/o	NN	I-NP	O
schizophrenia	schizophrenia	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
aud	aud	NN	I-NP	O
and	and	CC	I-NP	O
vis	vis	NN	I-NP	O
hallucinations	hallucination	NNS	I-NP	O
-LRB-	-LRB-	RBR	B-ADJP	O
chronic	chronic	JJ	I-ADJP	O
,	,	,	O	O
for	for	IN	B-PP	O
years	year	NNS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

ALso	ALso	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
issue	issue	NN	B-NP	O
of	of	IN	B-PP	O
domestic	domestic	JJ	B-NP	O
violence	violence	NN	I-NP	O
from	from	IN	B-PP	O
first	first	JJ	B-NP	O
husband	husband	NN	I-NP	O
but	but	CC	B-PP	O
per	per	IN	B-PP	O
social	social	JJ	B-NP	O
work	work	NN	I-NP	O
-	-	HYPH	O	O
this	this	DT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
remote	remote	JJ	B-ADJP	O
.	.	.	O	O

SW	SW	NN	B-NP	O
spoke	speak	VBD	B-VP	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
psych	psych	NN	I-NP	O
consult	consult	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-SBAR	O
psych	psych	NN	B-NP	O
issues	issue	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Social	Social	NNP	B-NP	O
Work	Work	NNP	I-NP	O
is	be	VBZ	B-VP	O
seeing	see	VBG	I-VP	O
patient	patient	NN	B-NP	O
regarding	regard	VBG	B-VP	O
getting	get	VBG	I-VP	O
her	her	PRP$	B-NP	O
section	section	NN	I-NP	O
8	8	CD	I-NP	O
housing	housing	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
FEN	FEN	NNP	I-NP	O
-	-	HYPH	O	O
Monitor	Monitor	NNP	B-NP	O
Lytes	Lytes	NNP	I-NP	O
,	,	,	O	O
replace	replace	NN	B-NP	O
Mg	Mg	NNP	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Ppx	Ppx	NN	I-NP	B-protein
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
CODE	CODE	NN	I-NP	O
-	-	HYPH	B-NP	O
Full	Full	JJ	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Sol	Sol	NNP	B-NP	O
Kragt	Kragt	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
nurse	nurse	NN	I-NP	O
.	.	.	O	O

it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
maintain	maintain	VBP	B-VP	O
your	your	PRP$	B-NP	O
careful	careful	JJ	I-NP	O
low	low	JJ	I-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
too	too	RB	B-NP	O
many	many	JJ	I-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
end	end	VB	I-VP	O
up	up	RP	B-PRT	O
back	back	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
your	your	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Be	Be	VB	B-VP	O
very	very	RB	B-ADJP	O
strict	strict	JJ	I-ADJP	O
about	about	IN	B-PP	O
taking	take	VBG	B-VP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

Seek	Seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SCHEFFEL	SCHEFFEL	NNP	B-NP	O
,	,	,	O	O
SHANE	SHANE	NNP	B-NP	O
L	L	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GE803	GE803	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/21/05	2/21/05	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

